180 related articles for article (PubMed ID: 35117257)
1. Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme.
Yin J; Liu JS; Feng M; Li JM; Lu S; Yang M; Cao BR; Lang JY; Zhu XD
Transl Cancer Res; 2020 Oct; 9(10):6487-6504. PubMed ID: 35117257
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme.
Ye Y; Zhong W; Qian J; Zhang J; Xu T; Han R; Han J; Wang C; Song L; Zeng X; Wang H
Front Cell Dev Biol; 2023; 11():1042490. PubMed ID: 36711038
[No Abstract] [Full Text] [Related]
3. Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.
Lin B; Madan A; Yoon JG; Fang X; Yan X; Kim TK; Hwang D; Hood L; Foltz G
PLoS One; 2010 Apr; 5(4):e10210. PubMed ID: 20419098
[TBL] [Abstract][Full Text] [Related]
4. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.
Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
[No Abstract] [Full Text] [Related]
5. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
6. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma.
Liu S; Geng R; Lin E; Zhao P; Chen Y
Front Genet; 2021; 12():602160. PubMed ID: 33732282
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
Guo SK; Shen MF; Yao HW; Liu YS
Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
[TBL] [Abstract][Full Text] [Related]
8. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
[TBL] [Abstract][Full Text] [Related]
9. Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI.
Zhang S; Zhang W; Wu B; Xia L; Li L; Jin K; Zou Y; Sun C
Medicine (Baltimore); 2022 Nov; 101(45):e31418. PubMed ID: 36397358
[TBL] [Abstract][Full Text] [Related]
10. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
[TBL] [Abstract][Full Text] [Related]
11. T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
Oncol Lett; 2021 Apr; 21(4):252. PubMed ID: 33664816
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma.
Fang D; Lu G
Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873
[TBL] [Abstract][Full Text] [Related]
13. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
[TBL] [Abstract][Full Text] [Related]
14. PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme.
Qiao H; Li H
Pharmgenomics Pers Med; 2023; 16():991-1009. PubMed ID: 37964785
[TBL] [Abstract][Full Text] [Related]
15. Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis.
Shi M; Wei Y; Guo R; Luo F
J Inflamm Res; 2024; 17():2285-2298. PubMed ID: 38645878
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of glutathione peroxidase 2 in glioblastoma multiforme.
Guo B; Liao W; Wang S
Transl Neurosci; 2021 Jan; 12(1):32-39. PubMed ID: 33552592
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of expression, prognosis and immune infiltration for TIMPs in glioblastoma.
Han J; Jing Y; Han F; Sun P
BMC Neurol; 2021 Nov; 21(1):447. PubMed ID: 34781885
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
[TBL] [Abstract][Full Text] [Related]
20. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
